Stock Movers: Moderna Surges, Constellation Energy Dips, Carmax Outperforms

Moderna's Market Rebound

• 💡 Moderna (MRNA) experienced a significant surge this week, closing up 22% week-over-week, its best performance since May 2024.
• 🔑 This rise was influenced by a patent appeal loss for Arbutus Biopharma against Moderna, broader gains in vaccine makers amid reaffirmed recommendations, and Moderna's revenue forecast meeting estimates.
• ⚠️ Despite recent gains, technicians note Moderna is in a rounding bottom pattern, and its performance is still not as strong as a couple of years ago.

Constellation Energy's Decline

• 📉 Constellation Energy (CEG) saw a decline of over 10% this week, its worst performance since April.
• ⚡ The drop is linked to energy policy news, specifically a plan to address data center energy costs by having tech companies fund new power plants.
• 📊 Investors are forecasting reduced earnings for utility companies like Constellation Energy due to this proposed emergency power auction.
• ⏳ The fundamental story involves infrastructure investments for power supply taking years, raising questions about the short-term impact on these companies.

Carmax's Strong Start to 2026

• 🚀 CarMax (KMX) has had a strong start to 2026, up 26% year-to-date, outperforming the S&P 500, MAG 7, and its peer Carvana.
• 📈 This performance is comparable to tech-focused stocks like Micron and Western Digital, driven by investors buying the November dip.
• 📊 Preliminary data suggests used car sales are trending higher year-over-year, benefiting both CarMax and Carvana.
• 🔍 CarMax's significant gains this year, especially compared to Carvana, are notable within the used car sector.